Biomarkers in epilepsy: Introduction

Biomarkers in Medicine

Volumn 5, Issue 5, 2011, Pages 537-544

  Engel, Jerome ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

biomarkers; drug development; epileptogenesis; epileptogenicity; pharmacotherapy; surgical therapy

Indexed keywords

ANTICONVULSIVE AGENT; BIOLOGICAL MARKER;

APLASTIC ANEMIA; BRAIN ELECTROPHYSIOLOGY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE MODEL; DISEASE PREDISPOSITION; DRUG EFFICACY; DRUG TOLERABILITY; EPILEPSY; EPILEPTOGENESIS; HUMAN; LIVER TOXICITY; MOLECULAR BIOLOGY; NEUROIMAGING; NEUROSURGERY; NONHUMAN; REVIEW; RISK FACTOR; SEIZURE; STEVENS JOHNSON SYNDROME;

BIOLOGICAL MARKERS; DRUG DISCOVERY; EPILEPSY; HUMANS; RISK FACTORS;

EID: 80054825753     PISSN: 17520363     EISSN: 17520371     Source Type: Journal    
DOI: 10.2217/bmm.11.62     Document Type: Review

References (33)

1. Epilepsy: A Comprehensive Textbook (2nd Edition). Engel J Jr, Pedley TA (Eds). Lippincott Williams & Wilkins, Philadelphia, PA, USA (2008)
2. The Treatment of Epilepsy (3rd Edition). Shorvon S, Perucca E, Engel J Jr (Eds). Wiley-Blackwell, Chichester, UK (2009).
3. Trusheim MR, Berndt ER, Douglas FL. Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers. Nat. Rev. Drug Discov. 6, 287-293 (2007). (Pubitemid 46505879)
4. Katz R. Biomarkers and surrogate markers: an FDA perspective. NeuroRx 1, 189-195 (2004). (Pubitemid 46604746)
5. Fisher RS, van Emde Boas W, Blume W, et al. Epileptic seizures and epilepsy. Definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 46, 470-472 (2005). (Pubitemid 40470667)
6. Ottman R, Hirose S, Jain S, et al. Genetic testing in the epilepsies - report of the ILAE Genetics Commission. Epilepsia 51(4), 655-670 (2010).
7. Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 51, 676-685 (2010).
8. Kellaway P, Saltzberg B, Frost JD Jr, Crawley JW. Relationship between clinical state, ictal and interictal EEG discharges and serum drug levels: generalized epilepsy/ ethosuximide. Neurology 29, 559 (1979) (Abstract).
9. Frost JD Jr, Kellaway P, Hrachovy RA, Glaze DG, Mizrahi EM. Changes in epileptic spike configuration associated with attainment of seizure control. Ann. Neurol. 20, 723-731 (1986).
10. Epstein CM, Michelucci R, Hallett M. Transcranial magnetic stimulation. In:Epilepsy: A Comprehensive Textbook (2nd Edition) . Engel J Jr and Pedley TA (Eds). Lippincott Williams & Wilkins, Philadelphia, PA, USA (2008).
11. Chen P, Linn JJ, Lu CS, et al. Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan. N. Engl. J. Med. 364, 1126-1133 (2011).
12. Chung WH, Hung SI, Hong HS, et al. Medical genetics: a marker for Stevens- Johnson syndrome. Nature 428, 486 (2004).
13. Begley CE, Famulari M, Annegers JF, et al. The cost of epilepsy in the United States: an estimate from population-based clinical and survey data. Epilepsia 41, 342-351 (2000). (Pubitemid 30134292)
14. Engel J Jr. Current concepts: surgery for seizures. N. Engl. J. Med. 334, 647-652 (1996). (Pubitemid 126563386)
15. Berg AT, Langfitt J, Shinnar S, et al. How long does it take for partial epilepsy to become intractable? Neurology 60, 186-190 (2003).
16. Wiebe S, Blume WT, Girvin JP, Eliasziw M. A randomized, controlled trial of surgery for temporal lobe epilepsy. N. Engl. J. Med. 345, 311-318 (2001). (Pubitemid 32703233)
17. Engel J Jr, Wiebe S, French J, et al. Practice parameter: temporal lobe and localized neocortical resections for epilepsy. Neurology 60, 538-547 (2003).
18. Haneef Z, Stern J, Dewar S, Engel J Jr. Referral pattern for epilepsy surgery after evidence-based recommendations: a retrospective study. Neurology 75, 699-704 (2010).
19. Chugani DC, Chugani HT, Muzik O, et al. Imaging epileptogenic tubers in children with tuberous sclerosis complex using α-[11C]methyl-l-tryptophan positron emission tomography. Ann. Neurol. 44, 858-866 (1998). (Pubitemid 28558246)
20. Fedi M, Reutens D, Ozakawa H, et al. Localizing value of α-methyl-l-tryptophan PET in intractable epilepsy or neocortical origin. Neurology 57, 1629-1636 (2001). (Pubitemid 33055481)
21. Jacobs J, Zijlmans M, Zelmann R, et al. High-frequency electroencephalographic oscillations correlate with outcome of epilepsy surgery. Ann. Neurol. 67, 209-220 (2010).
22. Ogren JA, Wilson CL, Bragin A, et al. Three-dimensional surface maps link local atrophy and fast ripples in human epileptic hippocampus. Ann. Neurol. 66, 783-791 (2009).
23. Andrade-Valenca LP, Dubeau F, Mari F, Zelmann R, Eng M, Gotman J. Interictal scalp fast oscillations as a marker of the seizure onset zone. Neurology 77(6), 524-531 (2011).
24. White HS. Antiepileptic drug discovery. In:The Treatment of Epilepsy (3rd Edition) . Shorvon S, Perucca E, Engel J Jr (Eds). Wiley-Blackwell, Chichester, UK (2009).
25. Lo¨scher W, Brandt C. Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research. Pharmacol. Rev. 62, 668-700 (2010).
26. Pitkänen A. Therapeutic approaches to epileptogenesis - hope on the horizon. Epilepsia 51, 2-17 (2010).
27. Engel J Jr. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia 42, 796-803 (2001). (Pubitemid 32605946)
28. Kwan P, Arzimanoglou A, Berg AT, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 51, 1069-1077 (2010).
29. Bragin A, Wilson CL, Almajano J, Mody I, Engel J Jr. High frequency oscillations after status epilepticus: epileptogenesis and seizure genesis. Epilepsia 45, 1017-1023 (2004). (Pubitemid 39238110)
30. Roch C, Leroy C, Nehlig A, Namer IJ. Predictive value of cortical injury for the development of temporal lobe epilepsy in 21-day-old rats: an MRI approach using the lithium-pilocardpine model. Epilepsia 43, 1129-1136 (2002). (Pubitemid 35176117)
31. Shinnar S, Hesdorffer DC, Nordli DR Jr, et al. Phenomenology of prolonged febrile seizures: results of the FEBSTAT study. Neurology 71, 170-176 (2008).
32. Jacobs MP, Fischbach GD, Davis MR, Dichter MA, Dingledine R, Lowenstein DH. Future directions for epilepsy research. Neurology 57, 1536-1542 (2001). (Pubitemid 33055465)
33. Kelley MS, Jacobs MP, Lowenstein DH. NINDS Epilepsy Benchmarks. Epilepsia 50(3), 579-582 (2009).